SCIMEDX PHASE II MPO IGG ANTIBODY EIA (1281)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II MPO IGG ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-myeloperoxidase (MPO) antibodies (K010289 | K010289) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Roche Diagnostics Hitachi 917View Complexity
Helena Laboratories Titan Gel ImmunoelectrophoresisView Complexity
Roche Diagnostics Hitachi 911View Complexity
Coulter Profile SystemView Complexity
The Binding Site OptiliteView Complexity
TheraTest Laboratories EL-ANA/7S (ssDNA,dsDNA,Sm,RNP/Sm,SSA,SSB,Scl-70)View Complexity
Technicon Immuno 1 SystemView Complexity
Roche Diagnostics Cobas Mira PlusView Complexity
Phadia ImmunoCAP 100View Complexity
Olympus AU640View Complexity